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ABSTRACT

ARTICLE HISTORY

Despite rutin, extracted from black mulberry, has several phar
macological activities, its exact effect against hepatic fibrosis
remains incompletely identified. Accordingly, this study investi
gates whether rutin is a promising candidate for treating hepa
tic fibrosis and to clarify its underlying antifibrotic mechanisms
in vitro and in vivo. In vitro studies were performed on hepatic
stellate cell line (HSC-T6) whereas liver fibrosis was established
in rats via chronic thioacetamide (TAA)-intoxication. Rats were
divided into (i) normal, (ii) TAA-intoxicated rats; TAA-intoxicated
rats treated with (iii) silymarin or (iv) rutin. Levels of ALT, AST,
platelet-derived growth factor-BB (PDGF-BB), tissue inhibitor
metalloproteinases type-1 (TIMP-1), hydroxyproline and expres
sion of proliferating cellular nuclear antigen (PCNA) together
with histological changes were examined. Activities of rutin on
TGF-β1, α-smooth muscle actin (α-SMA) and caspase-3 were
measured in vitro and in vivo. Rutin exhibited no marked HSCT6 cell death (IC50 = 460 µg.ml−1), however, it showed reduction
in HSCs activation (low TGF-β1 level and α-SMA positive cells)
and induced apoptosis (high caspase-3 positive cells). Rutin also
ameliorated liver functions, reduced hepatic levels of PDGF-BB,
TGF-β1, TIMP-1, hydroxyproline and restored PCNA, together
with attenuation in fibrosis score (S1 vs S4). Rutin could be
a promising candidate for treating hepatic fibrosis through
down-regulation of HSCs activation and induction of apoptosis.
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Introduction

Hepatic fibrosis is a naturally occurring wound healing response toward
chronic liver diseases including viral hepatitis (B and C), alcoholic or non
alcoholic fatty liver, parasitic and autoimmune diseases as well as drug
toxicity.[1] It is well established that the key fibrogenic cells in hepatic
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Pharmacology Department,
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fibrogenesis are the activated hepatic stellate cells (HSCs), although other cells
can make significant contributions.[2] Following hepatic injury, HSCs undergo
a process known as activation where they trans-differentiate into a highly
proliferative, contractile, and fibrogenic cell, thereafter they migrate to the
site of injury producing extracellular matrix (ECM), cytokines and growth
factors thus leading to the promotion of fibrosis.[3] As well, clearance of
activated HSCs was also shown to be an important contributor in the reversal
of hepatic fibrosis, through three main pathways: apoptosis, [4] senescence, [5]
or reversion to a quiescent phenotype.[6]
Despite the advances in clarification of the molecular mechanisms, the
underlying sources and mediators of fibrosis progression, no clinical transla
tion has been attained so far. Medicinal plants have gained popularity world
wide as antifibrotic agents[7] owing to being recognized as safe alternatives to
synthetic drugs, fitting into the image of a harmless kind of treatment by
entailing less toxicity, better therapeutic effect, good patient compliance and
cost effectiveness.[8]
Polyphenols are considered one of the most extensively studied phytochem
icals due to their abundance in fruits, vegetables, cereals and beverages.[8]
Mulberry fruits (Morus alba L.) are rich in phenolic compounds, including
flavonoids, anthocyanins and carotenoids, where rutin a well-known flavonoi
dal glycoside is present in the highest quantity.[9] Rutin is reported to exert
several pharmacological activities including anti-allergic, anti-inflammatory,
antitumor, antibacterial and antiviral properties. In addition, few articles
studied the hepatoprotective effects of rutin against nonalcoholic fatty liver
disease[10] and ethanol-induced toxicity.[11] Besides, to the best of the authors’
knowledge, limited number of articles documented the antiproliferative activ
ities of flavonoids, other than rutin, on HSC-T6 cell line .[12,13]
A number of hepatotoxins are employed for preclinical induction of liver
fibrosis, where chronic intoxication with thioacetamide (TAA) was established
as a reliable and reproducible experimental model perfectly mimic human
chronic hepatic diseases.[14] This could be due to its high selectivity to induce
various grades of liver damage including fibrosis, [15] cirrhosis, [14] hepatic
necrosis/apoptosis[16] and most importantly HSC activation.[17] Accordingly,
this study was oriented to investigate the potential antifibrotic efficacy of rutin,
attempted to provide insights on its exact mechanism of actions on HSCs both
in vitro, and in TAA-induced liver fibrosis.

Materials and Methods
Plant Materials

Black mulberry (Morus nigra) fruits were obtained in spring 2014, from the
Experimental Station of Medicinal and Aromatic Plants, Pharmacognosy
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Department, Faculty of Pharmacy, Cairo University. It was kindly identified in
Botany Department, Faculty of Science, Cairo University, Giza, Egypt.
A voucher specimen (2014067) was kept in the herbarium of the
Pharmacognosy Department, Faculty of Pharmacy, Cairo University.
Isolation and Extraction of Rutin

Fresh black mulberry fruits (1 kg) were cut into small pieces and percolated
with 2 L of 80% ethanol for 24 h. The extraction was repeated twice and the
ethanolic extract was evaporated under reduced pressure at 50°C using rotary
evaporator to yield 85.64 g. Fifty grams of the extract were fractionated over
Diaion HP column using 100% water, 50% methanol (MeOH) in water and
100% MeOH. The fractions were screened on thin layer chromatography
(TLC) using ethyl acetate-MeOH-water-formic acid (10:1.6:1.2:0.5 v/v/v/v).
Thirteen grams of 50% MeOH produced a major spot, which was yellow in
visible light and dull under UV (after spraying with AlCl3, Rf 0.54). This
fraction was then purified over several Sephadex LH 20 columns using MeOHwater (1:1 v/v) yielding 5 g of rutin compound.
Purity Testing of Rutin Using HPLC Analysis

The isolated rutin (5 mg) was dissolved in 5 mL methanol to obtain
a concentration of 1 mg.mL−1. The solution was filtered through 0.45 µM
membrane filter and subjected to HPLC analysis using an Agilent 1100 series
HPLC system (Agilent Technologies, Palo Alto, CA), equipped with
a quaternary pump G1311A, degasser G1322A, UV detector and an Agilent
ChemStation software. Separation was carried out on LiChrospher® RP-C18
endcapped (5 µm) (Merck, Germany). The mobile phase used was acetonitrile
(solvent A) and 0.3% phosphoric acid in water (solvent B). Gradient elution
was carried out at room temperature and at a flow rate of 1 mL.min−1 as
follows: 0–15 min 10–40% A in B, 15–20 min 40–70% A in B, 20–22 min
70–10% A in B. Measurements were made with an injection volume of 20 μL
and UV detection at 325 nm.
In Vitro Studies
Effect of Rutin on HSCs-proliferation, Activation and Apoptosis

An immortalized rat hepatic stellate cell line (HSC-T6) was used. Rutin was
dissolved in a small volume of dimethyl sulfoxide (DMSO) equivalent to 0.1%
final concentration (v/v). The solution was filtered through a 0.22-μm mem
brane and aliquots were stored at –20°C protected from light. Micro cultures
of 5 × 103 HSCs were cultured in 96-well tissue culture plates (Nunc, Roskilde,
Denmark) in 200 μL DMEM with 10% FBS. After 24 h, cells were treated with
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different concentrations of rutin (0–500 μg.mL−1) for 24 and 48 h and cell
survival ratios corresponding to untreated cells were examined. Each test was
performed in triplicate. The anti-proliferative effect of rutin on HSCs was
assessed using sulforhodamine base (SRB) assay and expressed in terms of the
IC50 value. HSCs activation was assessed via determining of TGF-β1 concen
trations in culture media using the commercial ELISA kit according to the
manufacturer’s instructions and immunocytostaining of HSCs with α-SMA;
moreover, HSCs apoptosis was assessed using caspase-3 immunocytostaining.
Effect of Rutin on Hepatocytes Viability/cytotoxicity

Primary hepatocytes were freshly isolated from rats by a two-step portal
collagenase perfusion of the liver.[18] Hepatocytes cell viability was assessed
by trypan blue dye exclusion. Cytotoxicity of rutin on isolated rat hepatocytes
was assessed by thiazolyl blue tetrazolium bromide (MTT) where primary
hepatocytes (5 × 103) were cultured in 96-wells tissue culture plates and treated
with the previously mentioned concentrations of rutin for 24- and 48-h. MTT
solution (20 µL of 0.5 mg.mL−1) was added to each well and incubated for
another 4 h at 37°C. The MTT-formazan generated by viable cells was mea
sured with an ELISA reader at 570 nm.
In Vivo Studies
Animals

Adult male Sprague-Dawley rats, weighing 250–300 g, obtained from the
animal house of Theodor Bilharz Research Institute (TBRI), Giza, Egypt,
were housed under an environmentally controlled room at 20–22 оC, 12 h
light/dark cycles and 50–60% humidity with free access to food and water ad
libitum throughout the acclimatization and experimental periods. All the
animal experiments comply with the Guide for Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH Publication
No. 85–23, revised 2011) and were approved by the Ethical Review Board of
TBRI as well as the research ethics committee for experimental and clinical
studies at Faculty of Pharmacy, Cairo University (PT: 559).
Experimental Design

Thirty-two rats were randomly divided into four groups, eight rats each: (i)
normal control; (ii) TAA-intoxicated rats injected intraperitoneally (i.p.) with
TAA in a dose of 200 mg.kg−1 twice weekly for 12 weeks.[19] TAA-intoxicated
rats administered (iii) silymarin (50 mg.kg−1[20]) or (iv) rutin (50 mg.kg−1;[21])
via oral gavage at daily doses for 8 weeks starting from the 5th week of TAAintoxication, where an apparent stage of fibrosis (S2) was verified, guided by
histopathological examination of hepatic tissues. Forty-eight h after the last
treatment, rats were killed by decapitation after an i.p. injection of ketamine
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(80 mg.kg−1). Blood samples were collected, centrifuged at 1,500 g; sera were
separated and then stored at –80оC for assessment of liver functions.
Moreover, livers were excised, weighed and subsequently divided into two
portions, the first was fixed in formalin for histopathological and immunohis
tochemical examinations. The second portion was washed with 0.9% ice-cold
saline and stored at – 80 оC for assessment of oxidative stress and fibrosis
markers as well as hydroxyproline (HP) contents.
Assessment of Liver Function and Oxidative Stress Markers

Serum alanine (ALT) and aspartate (AST) aminotransferases (Spectrum,
Egypt), the level of reduced glutathione (GSH) and the extent of lipid perox
idation expressed as malondialdehyde (MDA) formation in liver homogenates
(Biodiagnostic, Egypt) were determined spectrophotometrically using the
commercially available kits.
Assessment of Liver Fibrosis Markers

Tissue inhibitor matrix metalloproteinases, type-1 (TIMP-1), transforming
growth factor-β1 (TGF-β1) and platelet-derived growth factor-B (PDGF-B)
levels were measured in liver tissue homogenates by commercial ELISA kits (R
& D system, MN, USA). The content of HP was determined in liver tissue
samples as previously described.[22]
Liver Histology, Fibrosis Grade and Immunohistochemical Examinations

Liver specimens were fixed in 10% formalin and embedded in paraffin
blocks. Tissue sections were stained with hematoxylin-eosin (H&E)
(4 µm-thickness) and Sirius red (20 µm-thickness) for analysis of overall
liver histology and collagen distribution respectively. Collagen was quan
tified using imaging analysis software (Axiovision L.E. 4.8; Carl Zeiss
MicroImaging, Jena, Germany). Briefly, paraffin sections were stained in
0.1% Sirius red F3B (SR) in saturated picric acid. The red-stained area
(mm2) was measured in five consecutive fields (x 50) and a numerical
scoring system for morphometric analysis of hepatic fibrosis score was
used.[23] Additionally, liver sections were immunohistochemically stained
for caspase-3, PCNA and α-SMA with a horseradish-peroxidase complex
kit (Abcam Inc, UK). The percent of positively stained brown nuclei
(PCNA) or brown cytoplasm (α-SMA and caspase-3) was examined in
10 microscopic fields (at x 400 under Zeiss light microscopy, Jena,
Germany).
Statistical Analysis

Data are expressed as mean ± SEM. Statistical analysis was performed using
one-way ANOVA test followed by either Dunnett’s or Tukey’s post hoc test for

JOURNAL OF HERBS, SPICES & MEDICINAL PLANTS

327

multiple comparisons (GraphPad Software, San Diego, CA, USA, version
5.03). The difference in fibrosis stages between groups was analyzed by
Kruskal-Wallis test followed by Dunn’s multiple comparisons test.
Differences were considered significant at P < .05.

Results
Spectroscopic Data, Identification and Purity of Rutin
1

HNMR spectrum showed the characteristic signals for rutin (Table 1),
which was confirmed by the UV data (Table 2). The structure of the
isolated and identified rutin is shown in Fig. 1a. HPLC analysis of the
isolated rutin showed that its purity was reached to be 99.4% (Fig. 1b).

Table 1. 1HNMR and 13CNMR chemical shifts (δ
ppm) of the isolated rutin (DMSO-d6 for 1H 400
and 100 MHz for 13C).
Position
2
3
4
5
6
7
8
9
10
1`
2`
3`
4`
5`
6`
1``
2``
3``
4``
5``
6``
1```
2```
3```
4```
5```
6```

δH ppm
6.14 d (1.8)
6.44 d (1.8)
7.49 br.s
6.80 d (7.8)
7.54 dd (1.8, 7.8)
5.51 d (7.2)
5.10 d (2.1)
1.00 d (6.5)

δC ppm
158.2
136.0
178.9
161.8
99.6
165.6
94.2
158.9
104.5
122.6
116.7
144.9
148.5
115.9
122.9
100.8
74.5
76.5
72.1
76.2
66.6
101.1
71.0
71.5
73.0
68.4
17.9

Table 2. UV data of the isolated rutin.
MeOH
NaOMe
AlCl3
AlCl3/HCl
NaOAc.
NaOAc./H3BO3

257, 302sh, 359 (3-O-substituted flavonol)
266, 328sh, 412 (free OH on ring A & B)
272, 304sh, 420 (free OH on ring A & B)
266,298sh, 366, 402 (free OH at 5 & ortho OH at ring B)
264, 300sh, 380 (free OH at 7 & ortho OH at ring B)
260, 308sh, 377 (ortho OH at ring B)
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Figure 1. (a) Structure of the isolated and identified rutin. (b) HPLC analysis of the isolated rutin.

Effect of Rutin on HSCs Proliferation and Hepatocytes Viability

Treatment of cultured HSCs with rutin mitigated the HSCs proliferation in
a concentration- and time-dependent manner, displaying a 50% inhibition
concentration (IC50) of 461 µg.mL−1 at 48 h with 95% confidence interval (CI)
of 331.5–678.5 µg.mL−1 (Fig. 2a). Rutin also showed no inhibitory effects on
the viability of hepatocytes at 24- and 48-h. The viability of cells reached
approximately 89.56% at the highest concentration (500 µg.mL−1) and pro
longed exposure (48 h) (Fig. 2b).

JOURNAL OF HERBS, SPICES & MEDICINAL PLANTS

% Survival of HSCs

(a)

24 h
140
120
100
80
60
40
20
0

ab

b
a

48 h
b

a
b

a

a

a

b

a
b

Y=100/(1+10^((LogIC50−X)*Hill Slope)))

0

(b)
% Survival of hepatocytes

b

329

12.5 25 50 100 200 300 400 500
Concentrations (µg/mL)

24 h

48 h

120
b
100

b

b

80
60
40
20
0
0

12.5 25 50 100 200 300 400 500
Concentrations (µg/mL)

Figure 2. Effect of various concentrations of rutin on HSCs proliferation and hepatocytes viability.
Data are presented as the mean ± SEM (n = 4) of absorbance of three different experiments. aP <
.05 significantly different from corresponding untreated cells at 24 h, bP < .05 significantly different
from corresponding untreated cells at 48 h (one-way ANOVA followed by Dunnett’s multiple
comparison test). HSCs, hepatic stellate cells.

Effect of Rutin on HSCs Activation and Apoptosis

The image analysis of untreated activated HSCs showed enhanced α-SMA
expression, as illustrated by the increase in the number of α-SMA positively
stained cells. However, the exposure of activated HSCs to the IC50
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concentrations of rutin attenuated the HSCs activation, as advocated by the
pronounced reduction in α-SMA expression when compared to untreated cells
(Fig. 3a). The effect of rutin on HSCs apoptosis was also assessed using
caspase-3 expression. Untreated activated cells showed few positively cas
pase-3 stained cells, meanwhile, incubation of HSCs with rutin resulted in
a prominent elevation in caspase-3 expression by tenfold denoting a triggered
apoptotic effect of rutin on activated HSCs (Fig. 3a). Treatment of cultured
HSCs with rutin concentrations corresponding to approximately ¼ (125 µg.
mL−1), ½ (250 µg.mL−1), and onefold (500 µg.mL−1) the IC50 obtained after
48 h exhibited a decrease in TGF-β1 levels at a concentration of 500 µg.mL−1
by 19.65% as compared to untreated activated HSCs (Fig. 3b).
Effect of Rutin on Serum Liver Functions

Compared to TAA-intoxicated untreated group, treatment of TAAintoxicated rats with silymarin ameliorated the ALT levels by 29.54% whereas
treatment with rutin restored the normal ALT levels. Besides, both silymarin
and rutin reversed the elevated AST levels back to the normal (Fig. 4a).
Effect of Rutin on Liver GSH and MDA

Treatment with silymarin induced almost twofold increments (P < .05) in the
liver GSH content accompanied with a significant decline in liver MDA levels
by 36.05% when compared to TAA-intoxicated group. Meanwhile, rutin
normalized the liver GSH content and induced a significant reduction
(P < .05) in liver MDA levels by 28.25%, together with a significant elevation
in GSH content when compared to silymarin (Fig. 4b, c).
Effect of Rutin on Liver Fibrosis Markers

Administration of silymarin caused a significant reduction (P < .05) in hepatic
PDGF-BB, TGF-β1, TIMP-1 and HP levels by 29.6%, 37.28%, 14.76% and
47.42%, respectively, as compared to their corresponding TAA-intoxicated
groups. Administration of rutin significantly (P < .05) mitigated the hepatic
levels of PDGF-BB, TGF-β1, TIMP-1 and HP by 27.78%, 32.38%, 23.25% and
47.22%, respectively, as compared to TAA-intoxicated group (Fig. 5).
Effect of Rutin on Liver Fibrosis Grade and Histopathology

The effect of rutin on liver fibrosis grade and histopathological changes is
shown in Fig. 6. Normal liver sections showed a preserved hepatic architecture
with distinct hepatic cells, sinusoidal spaces and a central vein (Fig. 6a, b). On
the other hand, liver sections of the TAA-intoxicated rats revealed disrupted

JOURNAL OF HERBS, SPICES & MEDICINAL PLANTS

Control

331

Caspase-3

α-SMA

Rutin

TGF-β1 levels in media
(ng/mL)

a
2
1.6

a

1.2
0.8
0.4
0
0

125

250

500

Rutin concentrations (µg/mL)

b
Figure 3. (a) Photomicrographs showing the effect of IC50 concentrations of rutin on α-SMA and
caspase-3 immunoreactivity in activated HSCs versus untreated cells (x 400). The expressions of α-
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SMA and caspase-3 were estimated as the number of positively stained cells (red arrows). α-SMA:
alpha-smooth muscle actin. (b) Effect of ¼, ½ and one-fold IC50 concentrations of rutin on TGF-β1
concentrations in cultured HSCs’ media. Data are represented as mean ± SEM (n = 3). aP < .05
significantly different from corresponding untreated cells (one-way ANOVA followed by Tukey’s
multiple comparisons test). TGF-β1: transforming growth factor-β1.

architecture with extensive damage, characterized by centrilobular necrosis
and deposition of collagen bundles surrounding the lobules mainly in the
periportal regions that appeared as large fibrous septa forming regenerating
micro and macronodules (Fig. 6a, b) showing an elevated fibrosis score of
almost stage 4 (S4; Figure 6c). Administration of silymarin recovered the
damaged hepatic tissues to some extent, as denoted by reduced levels of
necrosis, mild thin and moderate fibrous collagen bands (Fig. 6a, b) as well
as mitigated fibrosis scores of approximately S2 (1.83 ± 0.31 vs 3.67 ± 0.21 for
TAA group; Figure 6c). Notably, better liver recovery was observed in rats
administered rutin where hepatic sections preserved their intact architecture
with almost normal hepatocytes and reduced fibrosis scores to S1 (1.00 ± 0.37
vs 3.67 ± 0.21 for TAA group; Figure 6c).

Effect of Rutin on HSCs Activation, Apoptosis and Hepatocytes Proliferation

Normal liver expressed α-SMA, a marker of activation, only in the hepatic
vascular smooth muscle cells of the blood vessels (Fig. 7). However, TAAintoxicated hepatic tissues showed a considerable elevation in α-SMA protein
expression as distinguished in areas of centrilobular and periportal fibrotic
bands. Treatment with silymarin and rutin, respectively, notably modulated
the α-SMA protein expression. Moreover, the number of caspase-3 positive
cells (apoptotic cells) detected in the normal control group was extremely low
and was significantly elevated in the TAA-intoxicated liver sections. Silymarin
and rutin depicted an increase in caspase-3 positive cells, respectively, as
compared to TAA-intoxicated hepatic sections. However, rutin showed better
enhancement in apoptosis when compared to silymarin treated group (Fig. 7).
Caspase-3 positively stained cells were portrayed in portal and periportal
areas, areas of activated HSCs, where collagen deposition is observed, rather
than in parenchymal cells (hepatocytes). Additionally, PCNA, a proliferation
marker for different cell types including hepatocytes, was expressed at basal
low levels in hepatocytes of normal control. Conversely, its expression was
upregulated in hepatocytes of TAA-intoxicated rats, which indicated
a pronounced proliferation in attempt to repair the damaged liver tissues.
Administration of silymarin distinctly diminished the proliferation of injured
hepatocyte as depicted by few PCNA-stained cells, while the administration of
rutin efficiently halted the proliferation of impaired hepatocytes (Fig. 7).
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Figure 4. Effect of rutin on serum ALT and AST (a) levels as well as hepatic GSH (b) and MDA (c)
levels. Data are represented as mean ± SEM (n = 8). aP < .05 significantly different from normal
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Figure 5. Effect of rutin on hepatic levels of PDGF-BB (a), TGF-β1 (b), TIMP-1 (c) and HP (d). Data are
represented as mean ± SEM (n = 8). aP < .05 significantly different from normal control, bP < .05
significantly different from TAA, cP <.05 significantly different from silymarin (one-way ANOVA
followed by Tukey’s multiple comparisons test). PDGF-BB: platelet-derived growth factor-BB, TGFβ1: transforming growth factor- β1, TIMP-1: tissue inhibitor of metalloproteinases Type-1, HP:
hydroxyproline, NC: normal control, TAA: thioacetamide, Sy: silymarin.

Discussion

In the last decade, epidemiological and experimental studies revealed
a positive correlation between the consumption of diet rich in fruits and
vegetables and the reduced risk of certain chronic diseases.[24] Although
there have been studies directed toward the evaluation of their hepatoprotec
tive potential, yet their true value in prevention of liver diseases and/or their
exact mechanisms of actions remains largely unknown.[25] This study
attempted to provide insights on the antifibrotic efficacy of rutin by focusing
mainly on their impact on HSCs in vitro and on TAA-induced liver fibrosis.
In the present study, treatment of cultured HSCs with rutin, for 48 h
illustrated a significant time- and concentration-dependent decline in the
proliferation of HSCs, displaying an IC50 of 461 µg.mL−1. This finding con
firms previous studies, which documented the antiproliferative activities of
flavonoids, other than rutin, on HSC-T6 cell line.[12,13] Such observed
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Figure 6. Effect of rutin on liver histopathology and hepatic collagen deposition. (a)
Histopathological examinations of hepatic sections stained with H&E (× 200), (b) picro-sirius red
stain (x 50) where the distribution of collagen fibers (black arrows) was visualized using imaging
analysis software. (c) Numerical scoring of fibrosis stages. Fibrosis was graded into four stages: (S0)
no fibrosis, (S1) expansion of fibrosis in portal area, (S2) peripheral fibrosis in portal area with
retention of intralobular architecture, (S3) fibrous septum accompanied by intralobular structural
disorders and (S4) early hepatic cirrhosis. Black arrows = strands of fibrosis. Data are expressed as
mean (n = 6) ± SEM; aP < .05 significantly different from normal control, bP < .05 significantly
different from TAA (differences in fibrosis stages were evaluated using Kruskal-Wallis followed by
Dunn’s multiple comparisons test). TAA: thioacetamide.

suppression in HSCs proliferation could be explained in the light of the
formerly reported in vitro antioxidant and pro-oxidant behaviors of polyphe
nolic compounds, particularly flavonoids where it selectively induced
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Figure 7. Photomicrographs of immunohistochemically stained hepatic sections for α-SMA (x 200),
caspase-3 (x 400) and PCNA (x 400). The expression of α-SMA, caspase-3 and PCNA were estimated
as percentage of positively stained cells (red arrows point to the brown positively stained cells). αSMA: alpha-smooth muscle actin, PCNA: proliferating cellular nuclear antigen, TAA: thioacetamide.

oxidative damage and cytotoxic effects on HSCs through maneuvering their
anti- and pro-oxidative capacities in hepatic malfunctions, thus promoting cell
death and inactivation of activated HSCs .[26]
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Results of this study revealed that also rutin triggered HSCs apoptosis; this
could be attributed, at least in part, to its pro-oxidant effects. Moreover, rutin
revealed its safety on primary isolated hepatocytes that exceeded 85% even
after the highest concentrations (up to 500 µg.mL−1) and prolonged exposure
(up to 48 h). These data add further support to previous study, which showed
that polyphenolics selectively induce oxidative damage and cytotoxic effects
on activated HSCs without showing any signs of cytotoxicity on
hepatocytes.[26]
In the present investigation, histopathological examinations of chronic
TAA intoxication for 12 weeks showed a disrupted architecture with extensive
damage that appeared in the form of micro and macronodules. This was
illustrated by an elevated fibrosis score (S4), which is a typical of TAAinduced liver fibrosis, and was evidenced by extensive increase in serum
ALT and AST levels. In this study, rutin ameliorated the elevated serum levels
of ALT and AST, denoting the property of rutin in maintaining the integrity of
the cell membrane of liver cells, thereby protecting the liver from the adverse
toxic effects of TAA. In addition, TAA-intoxicated rats exhibited a significant
depletion in GSH stores accompanied by an increase in MDA hepatic levels.
These results are in agreement with Shirin et al., [19] which indicated that TAA
metabolism resulted in an extensive production of ROS that exceeded the
capacity of endogenous antioxidant protective GSH to eliminate them, and
hence leading to GSH depletion. ROS also triggered the oxidation of poly
unsaturated fatty acids, thereby resulting in an increase in MDA
production.[27] Rutin replenished the hepatic GSH stores along with
a significant decline in hepatic MDA levels through the down-regulation of
ROS as formerly reported in CCl4-induced liver injury thus accelerating the
repair mechanism of the damaged cell membrane.[28]
Moreover, the free radicals resulting from TAA metabolism precede the
activation of HSCs, which in turn secrete fibrinogen and growth factors
leading to the progression of acute liver injury toward liver fibrosis. Among
the growth factors, TGF-β1 and PDGF-BB are considered the most potent
profibrogenic cytokines in liver fibrogenesis.[29] In the current study, rutin
alleviated the up-regulated hepatic levels of TGF-β1 and PDGF-BB as well as
α-SMA expression. Such outcomes could be explained and further strength
ened with those obtained in vitro where rutin reduced the TGF-β1 concentra
tions in culture media in a concentration-dependent manner as well as the
number of activated HSCs, as represented herein by the diminution in α-SMA
expression.
Additionally, activated HSCs act as the main source of excessive production
and deposition of ECM, where activated HSCs synthesize TIMPs that cause
further increase in collagen deposition mainly collagen type I.[30] In the
present study, TAA intoxication caused a dramatic increase in the hepatic
levels of TIMP-1 and HP (a major component of collagen), thus reflecting an
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increase for deposited collagen, which substantiates a previous study by Kadir
et al.[20] Results reported in this study were confirmed by the histological
examination, using sirius red stain, of TAA-intoxicated liver tissues, which
supported the presence of fibrosis (S4), numerous fiber extension and collagen
deposition around the hepatic lobules. A similar increase in collagen I and
TIMPs expression had been observed in other toxins-induced liver fibrosis in
rats.[31] Herein, besides the down-regulation of HSCs activation, rutin reduced
the fibrosis scores and TAA-induced collagen deposition and hence could help
in the prevention of the progression of liver fibrosis. These results were
comparable with a previous study, which showed that administration of
rutin markedly reduced TIMP-1 expression and correspondingly increased
collagen lysis.[32]
Furthermore, a small number of apoptotic cells were observed in TAAintoxicated liver tissues, as illustrated by few caspase-3 positively stained cells,
which is in harmony with the study of Kadir et al.[20] This could be attributed
to the centrilobular necrosis caused by TAA biotransformation, where the
toxicity induced by TAA favored necrosis over apoptosis.[33] Herein, rutin did
not only inhibit the activation or proliferation of HSCs but also triggered the
apoptosis of these cells in animals’ hepatic tissues as indicated by increased
caspase-3 expression in comparison to TAA-intoxicated rats. Such enhanced
apoptosis might be related to the suppressed TIMP-1 levels and deposited
collagen, recorded herein. These data confirm and extend the circumstantial
evidence from earlier studies, which documented that during recovery of liver
fibrosis, the apoptosis of activated HSCs led to reduction in both hepatic
collagen production and TIMPs over expression, thereby resulting in collagen
lysis and the up-regulation of caspases.[34]
Adding on, the proliferative activity of hepatocytes was examined via PCNA
staining. Hepatocytes of TAA-intoxicated rats showed more PCNA-positively
stained cells, indicating severe damage and increased number of necrotic cells;
this finding is in agreement with a former study, [35] which reported that
PCNA was elevated in hepatocytes of rats injected with TAA. In this study,
rutin inhibited the proliferation of damaged hepatocytes as indicated by
significant reduction in PCNA staining when compared to the higher damage
and the up-regulated PCNA expressed levels in the TAA-intoxicated rats. This
finding supported the idea that rutin did not only regulate HSCs activation but
also the cell cycle progression of hepatocytes thus playing a positive role in
liver regeneration.
Conclusions

In this work, the hepatoprotective and antifibrotic efficacy of rutin was com
pared to that of silymarin, and rutin exhibited some superior effects over
silymarin as illustrated by; restoration of the normal ALT levels and GSH
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stores, reduction of fibrosis score, enhancement of apoptosis as well as inhibit
ing the proliferation of impaired hepatocytes. In view of the obtained results, it
could be concluded that rutin could be a promising candidate in treating
hepatic fibrosis. This could be attributed to rutin ability to inhibit the pro
liferation and activation of HSCs together with increasing their apoptotic
tendency. Such obtained effects would urge further studies on the capability
of rutin to combat liver fibrosis.
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